Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
about
Autoimmune liver serology: current diagnostic and clinical challengesReview article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitisHepatitis C virus infection and type 1 and type 2 diabetes mellitusCirrhosis and autoimmune liver disease: Current understandingFetomaternal alloimmunity as a cause of liver disease.Autoimmunity and environment: am I at risk?Juvenile autoimmune hepatitis: Spectrum of the disease.Primary biliary cirrhosis: what do autoantibodies tell us?Liver immunology.Chronic intestinal pseudo-obstruction due to lymphocytic intestinal leiomyositis: Case report and literature review.Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance.Tracing environmental markers of autoimmunity: introducing the infectome.Primary biliary cirrhosis: family storiesThe immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis.Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies.Popular and unpopular infectious agents linked to primary biliary cirrhosis.Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis.Immunopathogenesis of primary biliary cirrhosis: an old wives' tale.High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?Epstein-barr virus as a trigger of autoimmune liver diseases.Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature.Aetiopathogenesis of autoimmune hepatitis.Autoimmune hepatitis. Part A: pathogenesis.Cutting edge issues in autoimmune hepatitis.Autoantibody-negative autoimmune hepatitis.Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.The overlap syndromes of autoimmune hepatitis.Autoimmune manifestations in viral hepatitis.Liver transplantation and autoimmune liver diseases.Paediatric autoimmune liver disease.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.Autoantibodies in autoimmune liver diseases.Autoimmune Hepatitis in the Liver Transplant Graft.Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitisMorbid Sequences Suggest Molecular Mimicry between Microbial Peptides and Self-Antigens: A Possibility of Inciting Autoimmunity.
P2860
Q24644140-4138A494-BD64-4C2D-B309-D82BB05111C1Q26827599-6C8C3FA3-5D41-4CBB-BC86-ADB7CA9F4D70Q26829202-55041847-651C-4378-940A-4A7CEE53789BQ28070154-56110B3A-F19E-44A6-A153-75E05283C693Q33423039-BEB580EE-DEF8-42D5-A211-530FFBFD1985Q33825348-924A8982-18E8-4552-9051-BAD3F2572D83Q33948215-33C0BC38-492E-4481-ABE1-A851617C90ABQ34041388-C7B3E157-98D3-41B7-8962-108F22681C60Q34359990-DCEA10F5-449F-4EC0-BEDE-7CD2578D1BAEQ34377961-20FF4228-F0B4-456F-8894-2C5EC59A2994Q34661366-31E7C28D-6923-4ED9-A5FA-524EA11484E5Q34671373-9856E436-B53D-4178-9A83-178F3EE3EDBAQ35038800-324ED7AB-8496-40F1-9194-BD889F332696Q35309836-72F6AED6-DEDA-42BA-B4D8-48D128D2D65BQ35309854-9C31AFA8-EEE1-4207-93A3-FEF90962CFE9Q35309882-13807ABC-B3AF-47E4-9B38-C75EE66F31F3Q35309953-12E625FC-A28B-41EA-BBA4-7D0B454600C7Q35614763-F3B6FC60-C6A1-4A47-AAD8-2D3B2390FD65Q35761342-7E2E9361-1682-48E9-8989-21105F49EC7BQ36010920-903E70FE-8D9A-4C47-BBC9-C616534F2B25Q36231193-570A26F0-6EA1-41B5-A10E-7AF0ED40B182Q36417949-64F0C36E-0655-4761-8149-5FD6CD7D2544Q37182932-1EF72B3C-382F-4D57-9AB1-2FD3F8E1A7EDQ37346054-B49F29A4-0696-40F2-AA65-49B827C694F5Q37826110-DC9C01E2-860B-4966-96BF-1E2BA5F1CAA4Q37970311-EFA7A2AE-73CB-4ABD-96FE-937EAD0488F1Q38007886-152ABD3D-A76A-41EC-B4FE-EBBDCEA66483Q38037392-E5A95118-2666-4E4F-A4ED-383664738396Q38046450-671E7FA4-B465-4C54-B6E9-85CDCC662F01Q38123133-ED121B28-C054-49DE-BB50-84BEBA1DE7F0Q38133924-57F2980A-0E0B-4DA9-AE18-C7DB9303C588Q38496935-CF0C7B3F-5412-48D4-81F4-8F2B058BCB96Q38497449-184FD436-6CAF-48AC-AC8D-88C0B6227518Q38584719-396D1BCF-680A-46D3-B12D-3B105B20E74EQ39212663-64DC1590-B8F1-49DD-A42A-B931162984D7Q42205181-B670FB5C-0575-4FB0-A89D-CCCCCB4AB089Q42369219-CED2E57B-64FD-4968-BAA7-A12D55B7EFA9Q47093391-C91A7975-C37E-402F-9F7C-D7EA354E7FC7
P2860
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@ast
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@en
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@nl
type
label
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@ast
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@en
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@nl
prefLabel
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@ast
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@en
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@nl
P2093
P2860
P1433
P1476
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
@en
P2093
Bogdanos DP
Choudhuri K
P2860
P304
P356
10.1034/J.1600-0676.2001.021004225.X
P577
2001-08-01T00:00:00Z